Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
about
Cancer-Related Fatigue, Version 2.2015.Fatigue in cancer: a review of literatureMethylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.Neuropsychiatric adverse effects of interferon-alpha: recognition and management.Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol.Evaluation and management of fatigue in oncology: a multidimensional approach.Supportive care of hematopoietic cell transplant patientsUse of methylphenidate in patients with cancer.Methylphenidate side effects in advanced cancer: a retrospective analysis.Fatigue in palliative care patients -- an EAPC approach.Cancer-related fatigue: the approach and treatment.Fatigue in patients with advanced cancer.Cancer-related fatigue: a practical review.Methylphenidate: established and expanding roles in symptom management.Psychiatric considerations in the oncology setting.Long-term methylphenidate intake in chronic fatigue syndrome.Methylphenidate for fatigue in ambulatory men with prostate cancer.Acquiring an evidence base in palliative care: challenges and future directions.A phase II study of methylphenidate for depression in advanced cancer.Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System.Efficacy of corticosteroids for cancer-related fatigue: A pilot randomized placebo-controlled trial of advanced cancer patients.Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study.
P2860
Q33878583-6BA6399C-2CD9-424D-A580-EDF0F2624206Q33915622-CAE89B2E-34A8-4825-A1C2-ABCA98C27D76Q34016523-8E6CDCAA-2DD6-4D93-97A9-410B0278B3ACQ34049203-B35FA94B-2ADD-4B0B-95DA-CA588987C707Q34081783-B78EA9FF-0E00-46F5-85F0-2599859502A7Q34687238-A3B5A73A-9047-47B7-A89B-511B6FBF4737Q35245106-1CAC299D-3D30-4213-B9F9-BA6BD1BC0324Q36243008-10922E9A-FE88-47F5-91D0-58AE77776EBFQ36383595-892C7BB8-232B-42BD-BAF4-8367175ECECBQ36800487-D3323CB7-1CAD-4D8B-A981-5A1D6F5E2406Q37063833-061F5125-3AB5-43C6-89B5-63E7E0D40857Q37390084-267A0B90-E78B-4497-B22F-12ADC200740FQ37816894-431A44C0-B9AB-4C89-AD0C-C78BB44EBA4BQ37843136-E8A04756-9685-4AE0-9AD7-8DA01E927938Q37965133-24529DFA-7A8B-4E68-B84D-E6E552BFE394Q38503207-9E76CDC5-B4BD-4D0B-B168-40D36216C70BQ39170713-3D331835-5594-471F-8E84-D59CDC2722D2Q39993765-CF4BA39A-8701-4E34-A23C-BA7D712608A9Q40354695-62A662A7-DBBF-4FB2-B86D-811F5F1E6BF6Q43802009-672A1D85-784D-4256-9765-5BACF1854D99Q44703687-9C33E6BC-4775-47DE-AC04-3E358AC2CD02Q48060742-CF1E1408-A126-4404-B14B-90C0A01083F8Q48340615-ADBA7082-D9D5-43B0-A667-1EAFBE874D52
P2860
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
@en
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
@nl
type
label
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
@en
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
@nl
prefLabel
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
@en
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
@nl
P2093
P2860
P1476
Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
@en
P2093
P2860
P304
P356
10.1177/104990910101800310
P577
2001-05-01T00:00:00Z